Advisory Committee on Organ Transplantation; Notice of Meeting, 43094 [2012-17830]
Download as PDF
<![CDATA[
43094
Federal Register / Vol. 77, No. 141 / Monday, July 23, 2012 / Notices
public conduct during advisory
committee meetings.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
Dated: July 17, 2012.
Jill Hartzler Warner,
Acting Associate Commissioner for Special
Medical Programs.
[FR Doc. 2012–17881 Filed 7–20–12; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Advisory Committee on Organ
Transplantation; Notice of Meeting
mstockstill on DSK4VPTVN1PROD with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), notice is hereby given
of the following meeting:
Name: Advisory Committee on Organ
Transplantation (ACOT).
Date and Time: August 28, 2012,
8:00 a.m. to 4:30 p.m. Eastern Daylight Time.
Place: Rockville Hilton Hotel, 1750
Rockville Pike, Rockville, MD 20852.
Status: The meeting will be open to the
public.
Purpose: Under the authority of
42 U.S.C. 217a, Section 222 of the Public
Health Service Act, as amended, and 42 CFR
121.12 (2000), ACOT was established to
assist the Secretary in enhancing organ
donation, ensuring that the system of organ
transplantation is grounded in the best
available medical science, and assuring the
public that the system is as effective and
equitable as possible, and, thereby,
increasing public confidence in the integrity
and effectiveness of the transplantation
system. ACOT is composed of up to 25
members, including the Chair. Members are
serving as Special Government Employees
and have diverse backgrounds in fields such
as organ donation, health care public policy,
transplantation medicine and surgery, critical
care medicine and other medical specialties
involved in the identification and referral of
donors, non-physician transplant
professions, nursing, epidemiology,
immunology, law and bioethics, behavioral
sciences, economics and statistics, as well as
representatives of transplant candidates,
transplant recipients, organ donors, and
family members.
Agenda: The Committee will hear reports
including those from the three ACOT Work
Groups: Declining Rates of Donation/
Geographical and Other Variations in Organ
Distribution, Alignment of CMS Regulatory
Requirements with OPTN and HRSA, and
Brain Death Determination. Agenda items are
subject to change as priorities indicate.
After Committee discussion, members of
the public will have an opportunity to
comment. Because of the Committee’s full
agenda and timeframe in which to cover the
VerDate Mar<15>2010
19:21 Jul 20, 2012
Jkt 226001
agenda topics, public comment will be
limited. All public comments will be
included in the record of the ACOT meeting.
Meeting summary notes will be posted on the
Department’s donation Web site at
https://www.organdonor.gov/legislation/
advisory.html#meetings.
The draft meeting agenda will be posted on
https://www.team-psa.com/ACOT/
Summer2012/. In order to register for this
meeting, please visit the Meeting Registration
Page. The deadline to register is August 13,
2012. For all logistical questions and
concerns, please contact Brittany Carey of
PSA at 703–889–9033 or
bcarey@explorepsa.com.
Public Comment: Persons interested in
providing an oral presentation should submit
a written request, along with a copy of their
presentation to: Passy Tongele, DoT,
Healthcare Systems Bureau (HSB), Health
Resources and Services Administration
(HRSA), Room 12C–06, 5600 Fishers Lane,
Rockville, Maryland 20857 or email at
ptongele@hrsa.gov. Requests should contain
the name, address, telephone number, email
address, and any business or professional
affiliation of the person desiring to make an
oral presentation. Groups having similar
interests are requested to combine their
comments and present them through a single
representative.
The allocation of time may be adjusted to
accommodate the level of expressed interest.
Persons who do not file an advance request
for a presentation, but desire to make an oral
statement, may request it at the time of the
public comment period. Public participation
and ability to comment will be limited to
space and time as it permits.
For Further Information Contact: Patricia
Stroup, Executive Secretary, ACOT,
Healthcare Systems Bureau, Health
Resources and Services Administration, 5600
Fishers Lane, Room 12C–06, Rockville,
Maryland 20857; telephone (301) 443–1127.
Dated: July 13, 2012.
Jennifer Riggle,
Deputy Director, Office of Management.
[FR Doc. 2012–17830 Filed 7–20–12; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Public Comment Period Extension for
the Final Supplementary Risk
Assessment for the Boston University
(BU) National Emerging Infectious
Diseases Laboratories (NEIDL)
A Notice of Availability for
the Final Supplementary Risk
Assessment for the Boston University
(BU) National Emerging Infectious
Diseases Laboratories (NEIDL) was
published in the Federal Register on
July 6, 2012. Upon the publication of
the Notice of Availability, a required
comment period of at least 30 day began
in which the National Institutes of
SUMMARY:
PO 00000
Frm 00050
Fmt 4703
Sfmt 9990
Health would accept and consider
comments from the public on the final
supplementary risk assessment. This
comment period was set to end on
August, 6, 2012. In order to provide the
public with additional time to review
and comment on the final
supplementary risk assessment, the
National Institutes of Health (NIH) has
decided to extend the public comment
period for the final supplementary risk
assessment until August 24, 2012.
Written comments on the
final supplementary risk assessment
must be postmarked no later than
August 24, 2012. Comments should be
sent to The National Institutes of Health,
Office of Biotechnology Activities, Attn:
NEIDL Risk Assessment, 6705
Rockledge Drive, Suite 750, Bethesda,
Maryland, 20892. Email comments
should be sent to NIH_BRP@od.nih.gov.
Please note that comments sent by email
must be received by 11:59 p.m. on the
last day of the comment period, August
24, 2012.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
National Institutes of Health Office of
Biotechnology Activities, 6705
Rockledge Drive, Suite 750, Bethesda,
Maryland, 20892. Telephone number:
(301) 496–9838. Electronic mail address:
NIH_BRP@od.nih.gov.
Availabilty of Copies and Electronic
Access: Copies of the Final
Supplementary Risk Assessment for the
Boston University National Emerging
Infectious Diseases Laboratory and the
accompanying reader’s guide may be
obtained at no cost by calling (301) 496–
9838, or by emailing requests to
NIH_BRP@od.nih.gov. The documents
are also available electronically at:
https://nihblueribbonpanel-bumcneidl.od.nih.gov/default.asp.
A copy of the final supplementary
risk assessment and the reader’s guide
has also been made available for review
at each of the following locations:
Central Branch of the Boston Public
Library, 700 Boylston Street, Boston,
MA; South End Library, 685 Tremont
Street, Boston, MA; Grove Hall Library,
42 Geneva Avenue; and Dudley Library,
65 Warren Street, Boston, MA.
Dated: July 18, 2012.
Ryan T. Bayha,
Science Policy Analyst, Office of Science
Policy, National Institutes of Health.
[FR Doc. 2012–18026 Filed 7–20–12; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\23JYN1.SGM
23JYN1
]]>Agencies
[Federal Register Volume 77, Number 141 (Monday, July 23, 2012)]
[Notices]
[Page 43094]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-17830]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Advisory Committee on Organ Transplantation; Notice of Meeting
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), notice is hereby given of the following
meeting:
Name: Advisory Committee on Organ Transplantation (ACOT).
Date and Time: August 28, 2012, 8:00 a.m. to 4:30 p.m. Eastern
Daylight Time.
Place: Rockville Hilton Hotel, 1750 Rockville Pike, Rockville,
MD 20852.
Status: The meeting will be open to the public.
Purpose: Under the authority of 42 U.S.C. 217a, Section 222 of
the Public Health Service Act, as amended, and 42 CFR 121.12 (2000),
ACOT was established to assist the Secretary in enhancing organ
donation, ensuring that the system of organ transplantation is
grounded in the best available medical science, and assuring the
public that the system is as effective and equitable as possible,
and, thereby, increasing public confidence in the integrity and
effectiveness of the transplantation system. ACOT is composed of up
to 25 members, including the Chair. Members are serving as Special
Government Employees and have diverse backgrounds in fields such as
organ donation, health care public policy, transplantation medicine
and surgery, critical care medicine and other medical specialties
involved in the identification and referral of donors, non-physician
transplant professions, nursing, epidemiology, immunology, law and
bioethics, behavioral sciences, economics and statistics, as well as
representatives of transplant candidates, transplant recipients,
organ donors, and family members.
Agenda: The Committee will hear reports including those from the
three ACOT Work Groups: Declining Rates of Donation/Geographical and
Other Variations in Organ Distribution, Alignment of CMS Regulatory
Requirements with OPTN and HRSA, and Brain Death Determination.
Agenda items are subject to change as priorities indicate.
After Committee discussion, members of the public will have an
opportunity to comment. Because of the Committee's full agenda and
timeframe in which to cover the agenda topics, public comment will
be limited. All public comments will be included in the record of
the ACOT meeting. Meeting summary notes will be posted on the
Department's donation Web site at https://www.organdonor.gov/legislation/advisory.html#meetings.
The draft meeting agenda will be posted on https://www.team-psa.com/ACOT/Summer2012/. In order to register for this meeting,
please visit the Meeting Registration Page. The deadline to register
is August 13, 2012. For all logistical questions and concerns,
please contact Brittany Carey of PSA at 703-889-9033 or
bcarey@explorepsa.com.
Public Comment: Persons interested in providing an oral
presentation should submit a written request, along with a copy of
their presentation to: Passy Tongele, DoT, Healthcare Systems Bureau
(HSB), Health Resources and Services Administration (HRSA), Room
12C-06, 5600 Fishers Lane, Rockville, Maryland 20857 or email at
ptongele@hrsa.gov. Requests should contain the name, address,
telephone number, email address, and any business or professional
affiliation of the person desiring to make an oral presentation.
Groups having similar interests are requested to combine their
comments and present them through a single representative.
The allocation of time may be adjusted to accommodate the level
of expressed interest. Persons who do not file an advance request
for a presentation, but desire to make an oral statement, may
request it at the time of the public comment period. Public
participation and ability to comment will be limited to space and
time as it permits.
For Further Information Contact: Patricia Stroup, Executive
Secretary, ACOT, Healthcare Systems Bureau, Health Resources and
Services Administration, 5600 Fishers Lane, Room 12C-06, Rockville,
Maryland 20857; telephone (301) 443-1127.
Dated: July 13, 2012.
Jennifer Riggle,
Deputy Director, Office of Management.
[FR Doc. 2012-17830 Filed 7-20-12; 8:45 am]
BILLING CODE 4165-15-P
